Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 68

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 68
---
Floor
New York, NY 10004
Attention: Mark Zimkind
E -mail: mzimkind@continentalstock.com xxv Summary of the Proxy Statement / Prospectus This summary highlights selected information from this proxy statement / prospectus and does not contain all of the information that is important to you. To better understand the proposals to be submitted for a vote at the Special Meeting, including the Business Combination, you should read this entire document carefully, including the Business Combination Agreement, attached as Annex A to this proxy statement / prospectus. The Business Combination Agreement is the legal document that governs the Business Combination and the other transactions that will be undertaken in connection therewith. The Business Combination Agreement is also described in detail in this proxy statement / prospectus in the section entitled “The Business Combination Agreement.” This proxy statement / prospectus also includes forward -looking statements that involve risks and uncertainties. See “Cautionary Note Regarding Forward -Looking Statements.” Certain figures included in this section have been rounded for ease of presentation and, as a result, percentages may not sum to 100%. Parties to the Business Combination APx Acquisition Corp. I714 Westview Avenue
Nashville, TN 37205 APx Acquisition Corp. I is a blank check company incorporated as a Cayman Islands exempted company organized for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. OmnigenicsAI Corp89 Nexus Way
Camana Bay
Grand Cayman, KYI -9009
Cayman Islands OmnigenicsAI Corp is a newly incorporated Cayman Islands exempted company and was incorporated for the purpose of making acquisitions and investments, with the objective of acting as the publicly traded holding company for its subsidiaries. OmnigenicsAI is an artificial intelligence -drivengenomics company which aims to provide reliable biological data with a focus on early disease detection and health management. In addition, it aims to use diverse genomic technologies to provide personalized healthcare and tests which support a broad range of health conditions. Heritas Merger Sub Limited89 Nexus Way
Camana Bay
Grand Cayman, KYI -9009
Cayman Islands Heritas Merger Sub Limited is a newly incorporated Cayman Islands exempted company and a direct wholly owned subsidiary of OmnigenicsAI. Merger Sub was formed solely in contemplation of the Business Combination, has not commenced any operations, has only nominal assets and no liabilities or continent liabilities,